Business Context and Reporting Period
Creative Medical Technology Holdings, Inc., a Nevada corporation, filed this Form 8-K Current Report on March 19, 2020. The report details corporate governance actions taken by the Board of Directors and the sole holder of Series A Preferred Stock.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on a modification to the rights of security holders.
Material Changes
- Voting Rights Amendment: The Company filed a Certificate of Amendment to the Certificate of Designation for its Series A Preferred Stock.
- Voting Power Increase: The voting power per share of Series A Preferred Stock was increased from 6.67 votes to 30 votes.
- Shareholder Concentration: All 3,000,000 outstanding shares of Series A Preferred Stock are held by Timothy Warbington, the Company's Chief Executive Officer.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risks related to operations. The primary implication of the amendment is a significant increase in the voting control held by the CEO over the Company's affairs.
Investor Verification Checklist
- Verify the full text of the Certificate of Amendment (Exhibit 3.1) to understand any other modified terms beyond voting rights.
- Confirm the total outstanding share count of common stock to assess the relative voting power of the Series A Preferred Stock.
- Review recent filings to determine if this change in voting structure impacts pending corporate actions or board composition.